Old Web
English
Sign In
Acemap
>
authorDetail
>
Nan-Feng Fan
Nan-Feng Fan
Medicine
Pathology
Internal medicine
Cisplatin
Gastroenterology
2
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase II study of efficacy and safety of RC48-ADC in patients with locally advanced or metastatic HER2-overexpressing gastric or gastroesophageal junction cancers.
2020
Journal of Clinical Oncology
Zhi Peng
Tianshu Liu
Jia Wei
Airong Wang
Yifu He
Liuzhong Yang
Xizhi Zhang
Nan-Feng Fan
Suxia Luo
Jifang Gong
Zhen Li
Kangsheng Gu
Jin Wei Lu
Jianming Xu
Qingxia Fan
Rui Hua Xu
Liangming Zhang
Jianmin Fang
Yi Ba
Lin Shen
Show All
Source
Cite
Save
Citations (9)
S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.
2019
Journal of Clinical Oncology
Rui Hua Xu
Zhi Qiang Wang
Lin Shen
Wei Wang
Jian-Wei Lu
Guanghai Dai
Jianming Xu
Yanqiao Zhang
Xiao-Bing Chen
Yanhong Deng
Yun-Bo Zhao
Nan-Feng Fan
Gengsheng Yu
Wangjun Liao
Xia Yuan
You-En Lin
Guo Long Liu
Qing-Feng Zou
Show All
Source
Cite
Save
Citations (3)
1